CHILEAN ASTRAZENECA TRIAL SAW NO CASES OF BLOOD CLOTS - TRIAL LEADERS


25/04/2021




Aslıhan DOĞRU -TDO- The Latin American country of Chile has announced that the AstraZeneca vaccine developed against the new type of coronavirus (Covid-19) pandemic will only be given to men.

The government said the first AstraZeneca shipment to the country would be primarily for men only.

Chilean investigators testing the AstraZeneca-Oxford University Covid-19 vaccination in 2,200 people found no instances of blood clots among participants, they said on Friday.

Chile's Public Health Agency said last week that it had recommended the AstraZeneca vaccine to women over the age of 55 and men over 18.


porno izlebrazzers